SPI Pharma Introduces Platform for Orally Disintegrating Tablets
UltraBurst has a high disintegration speed, which is for all market segments, from prescriptions to nutraceuticals.
SPI Pharma introduced an excipient platform for flash orally disintegrating tablets (ODTs), which enables disintegration in less than ten seconds. ODTs are good for anyone with difficulty swallowing.
This platform, UltraBurst, is designed for direct compression. According to the July 12, 2021 press release, it can deliver the fastest disintegration of preformulated products on the market and maintains hardness, friability, API loading, and assorted tablet weights for anything from prescription drugs to nutraceuticals.
"Across a wide range of different API loadings and tablet sizes, we can demonstrate significant reduction in disintegration time against the current market alternatives,” said John McInerney, General Manager of the Excipients and Drug Delivery Systems Business Unit. “We see reductions in disintegration times between 20–40% without loss of tablet hardness or increased friability.”
Source: PR Newswire, SPI Pharma
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
